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Dietary protein restriction is an important treatment for
chronic kidney disease. Herein, we tested the effect of
low-protein or low-protein plus ketoacids (KA) diet in a
remnant kidney model. Rats with a remnant kidney were
randomized to receive normal protein diet (22%), low-protein
(6%) diet (LPD), or low-protein (5%) plus KA (1%) diet for
6 months. Protein restriction prevented proteinuria,
decreased blood urea nitrogen levels, and renal lesions;
however, the LPD retarded growth and decreased serum
albumin levels. Supplementation with KA corrected these
abnormalities and provided superior renal protection
compared with protein restriction alone. The levels of
Kruppel-like factor-15 (KLF15), a transcription factor shown to
reduce cardiac fibrosis, were decreased in remnant kidneys.
Protein restriction, which increased KLF15 levels in the
normal kidney, partially recovered the levels of KLF15 in
remnant kidney. The expression of KLF15 in mesangial cells
was repressed by oxidative stress, transforming growth
factor-b, and tumor necrosis factor (TNF)-a. The suppressive
effect of TNF-a on KLF15 expression was mediated by TNF
receptor-1 and nuclear factor-jB. Overexpression of KLF15 in
mesangial and HEK293 cells significantly decreased
fibronectin and type IV collagen mRNA levels. Furthermore,
KLF15 knockout mice developed glomerulosclerosis
following uninephrectomy. Thus, KLF15 may be an
antifibrotic factor in the kidney, and its decreased expression
may contribute to the progression of kidney disease.
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Restriction of dietary protein intake remains a common
practice for patients with chronic renal failure, although the
results from the MDRD (modification of diet in renal
disease) study are inconclusive.1 Overall, data from both
clinical and experimental studies suggest a beneficial effect of
a low-protein diet (LPD) on chronic kidney disease
(CKD).1–4 The mechanism(s) by which a LPD slows down
the progression of CKD are unknown. However, it is clear
that restriction of dietary protein intake reduces the
metabolic burden, especially the levels of urea nitrogen.4
Additionally, treatment of 5/6 nephrectomized rats, a model
of progressive CKD, with a LPD has been shown to preserve
the antioxidant capacity and decrease the levels of oxidative
stress in the remnant kidney.3 As decreased protein synthesis
because of insufficient amino-acid supply and malnutrition is
a concern for long-term protein restriction, ketoacids (KA),
a nitrogen-free substitution for the essential amino acids,
have been prescribed together with a LPD to patients with
advanced CKD.5,6 Nitrogen-free branched-chain KA are
equally efficient as their counterpart of essential amino acids
in protein synthesis.7 Furthermore, branched-chain KA have
been reported to inhibit renal gluconeogenesis and increase
liver albumin synthesis.7 In this study, we evaluated the effect
of a LPD with or without supplementation of KA on a
remnant kidney model.
Renal fibrosis, a result of extracellular matrix accumu-
lation in glomeruli and tubulointerstitium, is a hallmark
of progressive CKD.8 Multiple factors, such as chronic
inflammation, transforming growth factor-b (TGF-b),
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hemodynamic changes, and oxidative stress, have been
implicated in the development and progression of renal
fibrosis.9,10 Kruppel-like factors (KLFs) are a subclass of the
cys2/his2 zinc-finger family of transcriptional regulators.11,12
Thus far, 17 members of KLF have been identified and shown
to be key regulators in cell growth and differentiation,
inflammation, and metabolism.11,12 KLF15 was isolated and
cloned independently by two groups.13,14 KLF15 is expressed
abundantly in the kidney and liver, and has thus far been
identified as a regulator of gluconeogenesis, the cardio-
vascular response to stress, and adipocyte differentiation.13–17
As the levels of type I collagen transcription and the activity
of connective tissue growth factor promoter were decreased
by KLF15, KLF15 may also regulate the expression of
extracellular matrix.13,15,18 Here, we examine the level of
KLF15 expression in the remnant kidney. We found that
KLF15 expression was significantly decreased in remnant
versus normal kidney, and we explored the factor(s) that
might contribute to reduced KLF15 expression. Finally, we
examined the effects of altered KLF15 expression on the
production of extracellular matrix in mesangial cells and on
the development of renal fibrosis.
RESULTS
General
Body weight increased progressively in normal rats from 2 to
8 months of age (Figure 1a). There was no difference in the
growth curve between normal rats and 5/6 nephrectomized
rats fed with normal protein diet (NPD). Dietary protein
restriction significantly slowed down animal growth. At the
age of 8 months, the body weight of the rats in LPD group
was 466.3±35 g, which was lower than that of the animals in
NPD group (664.8±42 g, Po0.01). The loss of weight gain
was partially corrected by KA supplementation.
Serum albumin levels were significantly decreased in 5/6
nephrectomized rats in NPD group, and also low in 5/6
nephrectomized rats in LPD group (Figure 1b). Addition of
KA to the LPD prevented serum albumin from decreasing.
Proteinuria and renal function
Urinary protein excretion increased progressively in 5/6
nephrectomized rats in NPD group (Figure 2a). Dietary
protein restriction completely prevented the progression
of proteinuria. The effect was retained in animals fed with a
low-protein plus KA. Blood urea nitrogen levels were elevated
in NPD-fed rats after 6 months of 5/6 nephrectomy, and
was normal in LPD- and LPD supplemented with KA
(LPDþKA)-fed 5/6 nephrectomized rats (Figure 2b). How-
ever, dietary protein restriction with or without KA did not
reduce the increased serum creatinine levels in 5/6 nephrec-
tomized rats (Figure 2c).
Renal histology and extracellular matrix
Renal histology was normal in age-matched normal controls
(Figure 3a). There was a moderate expansion of mesangial
area and an increase in thickness of membranes of Bowman’s
capsules in glomeruli of NPD-fed 5/6 nephrectomized rats.
Severe tubulointerstitial lesions, including tubular atrophy,
dilatation, increased thickness of tubular basement mem-
branes, and fibrosis, were present in NPD-fed 5/6 nephrecto-
mized rats. Masson’s trichrome staining revealed intensive
interstitial fibrosis and extensive inflammatory cell infiltra-
tion in this group (Figure 3b). Restriction of dietary protein
intake decreased glomerular lesions and, more prominently,
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Figure 1 |General data of rats. Body weight (a) and serum
albumin levels (b) of control and 5/6 nephrectomized rats fed with
NPD, LPD, or LPDþ KA. Data are expressed as means±s.d.
*Po0.05, **Po0.01 versus LPD, or LPDþ KA; and ##Po0.01 versus
LPD; Po0.05 versus control or LPDþ KA. LPD, low-protein diet;
LPDþ KA, low-protein diet supplemented with ketoacids; NPD,
normal protein diet.
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Figure 2 |Renal function. Proteinuria (a), BUN (b), and Scr (c)
levels of control and 5/6 nephrectomized rats fed with NPD, LPD,
or LPDþ KA. Data are expressed as means±s.d. *Po0.05 versus
LPD or LPDþ KA; ##Po0.01 versus the other three groups; and
Po0.05 versus LPDþ KA. BUN, blood urea nitrogen; LPD, low-
protein diet; LPDþ KA, low-protein diet supplemented with
ketoacids; NPD, normal protein diet; Scr, serum creatinine.
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largely prevented the development of tubulointerstitial
lesions (Figure 3c–f). The presence of mesangial expansion
and tubulointerstitial fibrosis in NPD remnant kidneys was
associated with upregulation of extracellular matrix genes.
mRNA levels of type I, III, and IV collagen, and fibronectin
increased 6.1-, 11-, 2.2-, and 16.7-fold, respectively, in the
NPD remnant kidneys compared with the intact kidneys. The
levels of TGF-b1 mRNA were also significantly increased in
the NPD remnant kidney. Dietary protein restriction largely
prevented the increase in expression of extracellular matrix
genes, except for type IV collagen (Figure 4g–k). Fibronectin
immunohistochemical staining showed a marked increase in
staining in the glomeruli and tubulointerstitium of NPD
remnant kidneys. The staining was decreased in remnant
kidneys of LPD rats (Figure 4e and f).
Macrophage infiltration and expression of proinflammatory
genes
As shown in Figure 5, although CD68-positive macrophages
were barely seen in the kidneys of age-matched normal
control, they were frequently seen in the remnant kidneys of
normal protein-fed 5/6 nephrectomized rats. Macrophage
infiltration was substantially decreased in animals fed with
LPD, and was nearly absent in group fed with LPD plus KA.
mRNA levels of inflammatory genes including tumor
necrosis factor-a (TNF-a), monocyte chemotactic protein-1
(MCP-1), regulated on activation, normal T expressed and
secreted (RANTES), and chemokine (C-X-C motif) ligand-1
(CXCL-1) increased 3.7-, 11.1-, 2.6-, and 9.9-fold, respec-
tively, in the NPD remnant kidneys compared with the
normal kidneys. Dietary protein restriction largely prevented
the upregulation of TNF-a, MCP-1, and CXCL-1, but mRNA
levels of RANTES remained high in LPD group (Figure 5e–h).
Supplementation with KA augmented the anti-inflammatory
effect of dietary protein restriction, as indicated by a further
decrease in MCP-1, RANTES, and CXCL-1 mRNAs levels.
KLF15 mRNA and immunostaining
KLF15 mRNA expression was decreased by 80% in the NPD
remnant kidney compared with the age-matched normal
kidney (Figure 6f). The decrease was partly recovered by LPD
or LPDþKA feeding. As the expression of KLF15 in skeletal
muscle has been shown to be regulated by fasting,16 we
gave normal rats a high-protein diet or LPD for 2 days
and then measured renal KLF15 mRNA levels. Interestingly,
renal KLF15 mRNA levels were increased nearly 100% by
LPD (Figure 6g).
Anti-KLF15 antibody staining of the renal tissue showed
that there were large numbers of KLF15-positive cells in both
glomeruli and interstitium of normal rats (Figure 6a–d).
There was a mean of 109±13.4 KLF15-positive cells per
high-power field ( 400) in the normal kidneys. The number
of positive cells was drastically reduced in the NPD remnant
kidney (6.2±6.3 per high-power field) (Figure 6e). LPD
remnant kidneys had higher numbers of KLF15-positive cells
(56.2±12.9 per high-power field, Po0.01 compared with
NPD group). More positive cells were present in LPDþKA
group (81.2±5.34 per high-power field, Po0.01 compared
with LPD group).
Oxidative stress, TGF-b-, and TNF-a-mediated inhibition of
KLF15 mRNA expression
KLF15 mRNA expression was present in cultured mesangial
cells. To explore the underlying cause(s) of decreased KLF15
expression in the remnant kidney, the contribution of
oxidative stress, TGF-b, and TNF-a, all of which were
elevated in remnant kidney, to KLF15 mRNA expression was
examined. Oxidative stress induced by hydrogen peroxide
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Figure 3 |Renal pathology (Masson’s trichrome,  400). Representative of slide from control (a) and 5/6 nephrectomized rats fed with
NPD (b), LPD (c), or LPDþ KA (d). Increased fibrosis in both glomerulus and tubulointerstitial area, and a prominent inflammatory cell
infiltration were seen in tubulointerstitium of NPD-fed 5/6 nephrectomized rats. Semiquantitative measurements of glomerulosclerosis
(e) and interstitial fibrosis (f) revealed that dietary protein restriction decreased glomerulosclerosis index and interstitial fibrosis score.
*Po0.05 versus control or LPDþ KA; and ##Po0.01 versus control, LPD, or LPDþ KA. Data are expressed as means±s.d. LPD, low-protein
diet; LPDþ KA, low-protein diet supplemented with ketoacids; NPD, normal protein diet.
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(H2O2) significantly decreased KLF15 mRNA levels in
mesangial cells (Figure 7a). TGF-b and TNF-a also
significantly decreased KLF15 mRNA expression (Figure 7b
and c). The reduction of KLF15 expression by TNF-a
occurred at 2 h and gradually returned to normal levels
within 24 h (Figure 7c), suggesting an early and likely a direct
action of TNF-a. As TNF-a did not decrease KLF15 mRNA
levels in mesangial cells lacking TNF receptor-1 (TNFR1)
and in mouse embryonic fibroblasts from nuclear factor-kB
(NF-kB) subunit p65 knockout mice (Figure 7d and e), it is
likely that this suppressive effect of TNF-a was mediated by
TNFR1 and NF-kB.
Overexpression of KLF15 decreased extracellular matrix
KLF15 is a transcription factor that is actively involved in
regulation of multiple genes. As KLF15 has been shown to
have a protective role against cardiomyocyte hypertrophy and
heart fibrosis, we examined its role in extracellular matrix
regulation. Mesangial cells were transfected with a plasmid
containing a full-length KLF15 complementary DNA. An
increase in KLF15 mRNA expression was found in transfected
cells. This increase was associated with a decrease in
fibronectin mRNA and protein expression (Figure 8a and b).
Overexpression of KLF15 in HEK293 cells also reduced the
expression of type IV collagen and fibronectin in these
cells, suggesting that the inhibition of extracellular matrix
expression by KLF15 may not be a cell type-specific effect
(Figure 8c).
KLF15/ mice were more susceptible to glomerulosclerosis
To further explore the regulation of extracellular matrix
production by KLF15, we assessed the renal pathology of
KLF15/ mice. There was no obvious increase in mesangial
extracellular matrix in young KLF15/mice (data not shown).
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Figure 4 |Renal fibrosis expression. Fibronectin immunostaining (a–f) and mRNA levels of TGF-b and extracellular matrix genes (g–k).
Fibronectin staining was barely present in the control kidney (a,  200). Increased staining was visible in remnant kidney of NPD-fed animal,
especially in tubulointerstitium (b). Dietary protein restriction reduced fibronectin staining (c), and the reduction was even more obvious in
5/6 nephrectomized rats fed with LPDþ KA (d). Semiquantitative measurements of intensity and area of fibronectin staining showed that
kidneys from animals in LPD and LPDþ KA had weaker fibronectin staining in glomeruli (e) and tubulointerstitium (f) than kidneys from
animals in NPD. *Po0.05, **Po0.01 versus Control or LPDþ KA; and ##Po0.01 versus Control, LPD, or LPDþ KA. Real-time PCR analysis
of mRNA levels of TGF-b (g), fibronectin (h), type I (i), type III (j), and type IV collagen (k) in kidneys from control and 5/6 nephrectomized
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However, uninephrectomy caused a prominent glomerulo-
sclerosis in these mice, whereas glomerular mesangial area
remained essentially normal in wild-type mice after unine-
phrectomy (Figure 9a–d). Morphometric analysis showed a
100% increase in Periodic acid-Schiff-positive mesangial area
in uninephrectomized KLF15/ mice (Figure 9e).
DISCUSSION
Dietary protein restriction remains as an important measure
for the treatment of chronic renal failure. Consistent with
previous reports,1–4 we found in the present study that a LPD
decreased the severity of renal disease in 5/6 nephrectomized
rats. After 6 months of 5/6 nephrectomy, animals fed with a
normal protein chow (22%) developed severe proteinuria,
moderate to severe renal lesions, and renal function
insufficiency. Animals fed with a low-protein chow (6%)
did not develop proteinuria, had mild renal lesions, and a
normal blood urea nitrogen. However, serum creatinine
levels remained high in animals under LPD. Furthermore, 5/6
nephrectomized rats fed with a diet 70% lower in protein
showed signs of growth retardation, as evidenced by
substantially less weight gain from 2 to 8 months of age
compared with 5/6 nephrectomized rats fed a NPD. Serum
albumin levels were also reduced in the LPD-fed animals,
although they did not develop obvious proteinuria. Thus,
insufficient protein synthesis or undernutrition may have
occurred in these animals. This has always been a concern in
patients who undergo long-term dietary protein restric-
tion.6,19 Besides from an emphasis on giving patients
sufficient calorie from sources other than protein, supple-
mentation with essential amino acids or a-KA, or both, has
been recommended.5,6,20 Indeed, we found in this study that
the addition of KA to the LPD largely prevented the loss of
weight gain and completely normalized serum albumin
levels. As the beneficial effect of a LPD on CKD was
completely retained and supplementation of KA with a LPD
actually provided a better renal protection in 5/6 nephrecto-
mized rats, it may be necessary to add KA to LPDs. It is
unclear why serum creatinine levels remained high in 5/6
nephrectomized rats fed with a LPD with or without KA
supplementation, even though proteinuria and renal histol-
ogy were substantially improved.21
Multiple mechanisms, including decreases in nitrogen
waste, metabolic burden, and oxidative stress, have been
suggested for the beneficial effects of a LPD on the
progression of CKD.9,10,19 As CKD patients on LPDs were
associated with lower levels of serum C-reactive protein
compared with CKD patients on NPDs, a decrease in
inflammation may also be a mechanism.22,23 Our finding
that chronic inflammation, characterized by extensive
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Figure 5 |Renal inflammatory expression. Monocyte/macrophage immunostaining with an anti-CD68 antibody (a–d) and mRNA levels of
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macrophage infiltration and increased mRNA expression of
proinflammatory molecules, such as TNF-a, MCP-1, CXCL-1,
and RANTES, was substantially reduced in 5/6 nephrecto-
mized rats fed with the low-protein or low-protein plus KA
diets further supports an anti-inflammatory action of dietary
protein restriction.24,25
KLF15 is a transcription factor that has been shown to
have a role in heart fibrosis.15,18 The levels of KLF15 mRNA
and the number of KLF15-positive cells were drastically
decreased in the remnant kidney of 5/6 nephrectomized rats.
We found mRNA expression of KLF15 in mesangial cells but
not in proximal tubular cells (data not shown). mRNA levels
of KLF15 in mesangial cells were decreased by oxidative stress
(H2O2), TGF-b1, as well as TNF-a, all three factors that are
increased in the remnant kidney and several other forms of
progressive kidney disease.9,10,24–27 As the suppressive effect
of TNF-a on KLF15 mRNA expression was largely lost in cells
lacking TNFR1 or p65 subunit of NF-kB, both TNFR1 and
NF-kB are likely required for TNF-a-mediated inhibition of
KLF15 expression.28,29 A further examination of KLF15
promoter may help to clarify the role of NF-kB in regulating
KLF15 gene transcription. KLF15 is likely to be involved in
the regulati8n of multiple genes, including those participating
in glucose transport, glucose metabolism, ion transport, and
cardiomyocyte hypertrophy.13,18 We found that overexpres-
sion of KLF15 in mesangial cells and HEK293 cells resulted in
significantly decreased fibronectin and type IV collagen
expression, suggesting that KLF15 may also have a role in
extracellular matrix regulation. Our study on uninephrecto-
mized KLF15/ mice further showed that KLF15 may
protect against glomerular fibrosis. The improvement of
CKD by dietary protein restriction was associated with a
partial recovery of KLF15 expression in the remnant
kidney. This may be because of a decrease in oxidative stress
and to less of an increase in TGF-b and TNF-a in the
remnant kidney of the low-protein and low-protein plus KA-
fed 5/6 nephrectomized animals. Moreover, as the levels of
KLF15 in normal kidney were increased by dietary protein
restriction, this may also help to explain increased KLF15
expression in the low versus normal protein-fed 5/6
nephrectomized rats.
MATERIALS AND METHODS
Animals
Male Sprague–Dawley rats (200–250 g) were housed at optimal
temperature with a 12-h light–dark cycle, and free access to water.
The animals were randomly assigned to either the CKD group or the
sham-operated control group. Each animal in the CKD group
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Figure 8 |Overexpression of KLF15 decreased fibronectin and type IV collagen mRNA levels. Mesangial cells or HEK293 cells were
transiently transfected with a mouse KLF15 complementary DNA (cDNA) or a pcDNA3 plasmid. Cells were collected after 24 h of transfection
for determining mRNA levels by real-time PCR. Additionally, fibronectin produced by mesangial cells in both the supernatant and the
cell layer was measured by enzyme-linked immunosorbent assay. All experiments were repeated at least three times. (a) KLF15, a1
type IV collagen, and fibronectin mRNA levels (corrected by glyceraldehyde-3-phosphate dehydrogenase) in mesangial cells transfected
with or without KLF15 cDNA. The levels in control plasmid-transfected cells were arbitrarily defined as one. (b) Fibronectin levels in
both supernatant and cell layer were decreased by overexpression of KLF15 in mesangial cells. **Po0.01 versus control. (c) Overexpression
of KLF15 in HEK293 cells also decreased mRNA levels of a1 type IV collagen and fibronectin as determined by real-time PCR. **Po0.01
versus control. Data are expressed as means±s.d. KLF, Kruppel-like factor.
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underwent 5/6 nephrectomy as previously described.21 After 7 days
of nephrectomy, rats in CKD group were randomly assigned to three
dietary groups, namely, the NPD (22% protein, NPD), the LPD
(6% protein), or the LPDþKA (5% protein and 1% KA). All the
three diets were modified from AIN-93 (American Institute of
Nutrition Rodent Diets), and contained the same calorie content
(3.5 kcal/g), vitamins, and minerals. Animals were monitored for
6 months. The 24-h urine was collected, and animal was weighed
monthly. Blood and tissue samples were harvested at kill. Each
dietary group had at least six animals at the end of the experiments.
KLF15/ mice were generated and characterized as previously
described.16 These mice have been backcrossed to C57B6 back-
ground. One kidney in 3- to 5-month-old male KLF15/ and
wild-type mice (n¼ 4/group) was removed. The animals were killed
2 months after uninephrectomy.
To examine the correlation between dietary protein intake and
renal KLF15 mRNA levels, normal rats were fed with a high-protein
diet (30%) or a LPD (6%) for 2 days. Renal tissues were harvested to
determine KLF15 mRNA levels by real-time PCR.
Animal usage and all the experimental procedures were approved
by the Ethics Committees of the Second Military Medical University,
and followed the guidelines for the Care and Use of Laboratory
Animals by the National Research Council.
Blood and urine examination
Serum creatinine, blood urea nitrogen, serum albumin levels, and
24-h urinary protein excretion were determined colorimetrically
using the commercial kits (Cobas c 111, Roche, Basel, Switzerland).
Renal semiquantitative morphometry
Remnant or control kidneys were removed, fixed in 10% buffered
formalin, embedded in paraffin, and sliced to 3mm-thick sections.
Sections were stained by Masson’s trichrome. Renal pathology and
morphological analyses were performed by an experienced patho-
logist blinded to the source of the tissue. The extent of glomerular
sclerosis was assessed as described previously.30 At least 30 glomeruli
from each kidney were graded according to the following criteria: 0, no
sclerosis; 1, less than 25% cross-sectional sclerosis; 2, 25–50% sclerosis;
3, 50–75% sclerosis; and 4, over 75% sclerosis. The mean score per
glomerulus in each kidney was determined as the sclerosis index.31
Similarly, sections from the cortex of each kidney were graded for the
severity of interstitial fibrosis: 0, no evidence of interstitial fibrosis; 1,
less than 10% involvement; 2, 10–25% involvement; 3, 25–50%
involvement; 4, 50–75% involvement; and 5, more than 75%
involvement.32 The score for each section was recorded as the mean
of 20 random high-power ( 400) fields per section.
Periodic acid-Schiff staining was also used for histologic
examination of glomerular extracellular matrix and morphometric
analysis for quantitation of mesangial area as previously described.33
Immunohistochemistry/immunofluorescence
Immunoperoxidase staining was performed as described pre-
viously.34 Briefly, formalin-fixed and paraffin-embedded sections
were deparaffinized, and endogenous peroxidase was inactivated
with 0.3% H2O2. Sections were then incubated in a blocking
solution for 10min, followed by monoclonal mouse anti-rat CD68,
a marker for monocyte/macrophage (1:200, Thermo, Fremont, CA)
or monoclonal mouse anti-rat fibronectin (1:200, Santa Cruz
Biotechnology, Santa Cruz, CA) overnight at 4 1C. The next day,
sections were washed three times with phosphate buffered saline and
then incubated with the second antibody for 15min. Positive
staining was revealed by peroxidase-labeled streptavidin and
diaminobenzidine substrate. Nuclei were counterstained with
hematoxylin. The control included a section stained with only
second antibody or without the antibody.
For KLF15 staining, sections were blocked with 5% normal
donkey serum in phosphate buffered saline for 10min at room
temperature and then incubated with a goat anti-rat KLF15
antibody (1:200, Santa Cruz Biotechnology) at 4 1C overnight. The
reaction was visualized under a fluorescence microscope by a donkey
anti-goat IgG–FITC antibody (1:100, Santa Cruz Biotechnology).
Negative controls for immunofluorescence staining were performed
by a substitution of primary antibody with non-immune serum.
Real-time PCR
Total RNA was extracted from the renal cortex using RNase mini kit
(Invitrogen, Carlsbad, CA) and reverse transcribed. Primers for KLF15,
TNF-a, MCP-1, RANTES, CXCL-1, TGF-b1, fibronectin, type I, III,
and IV collagen, and glyceraldehyde-3-phosphate dehydrogenase
were designed and synthesized based on published sequences of
these genes as listed in Table 1.35 Real-time PCR was performed
using SYBR Green PCR Master Mix (Toyobo, Osaka, Japan) and
a Rotor-Gene-3000A Real-time PCR System (Corbett, Sydney,
Australia) according to the manufacturer’s protocol.
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Figure 9 |Renal pathology (PAS). Representative slides from
wild-type (a,  400; c,  800) and KLF15/ uninephrectomized
mice (b,  400; d,  800). Morphometric analysis further revealed
that mesangial area was increased in uninephrectomized KLF15/
but not in uninephrectomized wild-type mice (e). Data are
expressed as means±s.d. PAS, Periodic acid-Schiff; KLF15/,
Kruppel-like factor-15/; WT, wild type.
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Cell culture and KLF15 expression
Murine mesangial cells were obtained from young C57B6 wild-type
and TNFR1 knockout mice as previously described.36 A rat
mesangial cell line (RMC, CRL-2573) was purchased from American
Type Culture Collection (ATCC, Manassas, VA). Embryonic
fibroblasts from wild-type and NF-kB p65 (RelA)-deficient mice
were kindly provided by Dr Amer A Beg (Department of Biological
Sciences, Columbia University, New York, USA).37 To determine the
effect of TNF-a, TGF-b1, and H2O2 on KLF15 expression, mesangial
cells or mouse embryonic fibroblasts were seeded at 2 105/well in a
six-well plate. Some cells were treated with TNF-a (10 ng/ml),
TGF-b1 (10 ng/ml), or H2O2 (80–100 mm). Total RNA was extracted
from cells at designated time points after TNF-a treatment and at
8 h after TGF-b1 and H2O2 treatment. Additionally, wild-type and
TNFR1/ mesangial cells, as well as wild-type and RelA/
mouse embryonic fibroblast were treated with 10 ng/ml of murine
recombinant TNF-a for 2 h. KLF15 mRNA levels were determined
by real-time PCR.
To explore the function of KLF15, mesangial cells or HEK293
cells were transfected with a mouse KLF15 complementary DNA
expression vector using the transfection reagents from Invitrogen.
Total RNA, cellular protein, and culture supernatant were collected
from cells after 24 h of transfection to examine mRNA levels of
KLF15, a1 type IV collagen, and fibronectin, and were normalized to
glyceraldehyde-3-phosphate dehydrogenase mRNA levels. Addition-
ally, the production of fibronectin by KLF15-overexpressing and
control mesangial cells was determined by enzyme-linked immuno-
sorbent assay using commercial ELISA kits (R&D, Minneapolis,
MN). Briefly, 50 ml of incubation buffer, 50 ml of standard dilution
buffer, and 50 ml of sample (culture medium or cellular protein) or
known standard were dispensed into an antibody-coated 96-well
microplate. Then, 50 ml of biotinylated solution was added to each
well and incubated for 90min at room temperature. After four
washes, 100ml of streptavidin–horseradish peroxidase was added and
then incubated for 30min at room temperature. After an additional
four washes, 100 ml of stabilized chromogen was added and
incubated at room temperature in the dark for 30min. Finally,
100 ml of stop solution was added, and the optical density was
determined at 450 nm using an enzyme-linked immunosorbent
assay microtiter plate reader.
Statistics
Significance was determined by analysis of variance and t-test using
Stat View 4.0 (Abacus Concepts, Piscataway, NJ). Differences with P-
values of o0.05 were considered statistically significant.
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